Johnson & Johnson's single-dose COVID-19 vaccine gets emergency use nod in India, to be produced by Biological-E
Sunday, May 29, 2022
  • Circulation
  • Advertise
  • About Us
  • Contact Us
  • Privacy Policy
Organiser
  • ‌
  • Bharat
  • World
  • Editorial
  • Analysis
  • Opinion
  • Defence
  • Sports
  • Business
  • More
    • RSS in News
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Health
    • Obituary
SUBSCRIBE
No Result
View All Result
Organiser
  • ‌
  • Bharat
  • World
  • Editorial
  • Analysis
  • Opinion
  • Defence
  • Sports
  • Business
  • More
    • RSS in News
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Health
    • Obituary
No Result
View All Result
Organiser
No Result
View All Result
  • Home
  • Bharat
  • World
  • Editorial
  • Opinion
  • Analysis
  • Culture
  • Defence
  • RSS in News
  • Subscribe
Home Bharat

Johnson & Johnson’s single-dose COVID-19 vaccine gets emergency use nod in India, to be produced by Biological-E

WEB DESK by WEB DESK
Aug 7, 2021, 02:18 pm IST
in Bharat
Jeay Sindh Freedom Movement chairman Sohail Abro

Jeay Sindh Freedom Movement chairman Sohail Abro

Share on FacebookShare on TwitterTelegramEmail

 

Johnson and Johnson’s single-dose COVID-19 vaccine has been given approval for emergency use in India. It is the third foreign-made vaccine to get Emergency Use Authorisation in India after the US's Moderna and Russia's Sputnik V. 

Announcing the news on Twitter, the Health Minister said India now has five emergency use authorization (EUA) vaccines, adding that this will further boost the nation's collective fight against coronavirus.

"India expands its vaccine basket! Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines. This will further boost our nation's collective fight against #COVID-19," he tweeted.

J&J had asked for authorisation after data from its Phase 3 trials said its single-dose COVID shot is 85.4% effective in preventing severe disease across all regions studied. It also showed protection of 93.1% against COVID-19 related hospitalisation and death, 28 days from vaccination.

"Biological E will be an important part of our global supply chain network, helping to supply our Johnson & Johnson COVID-19 vaccine through the extensive collaborations and partnerships we have with governments, health authorities and organisations such as Gavi and the COVAX Facility," Johnson and Johnson said in a statement. 

ShareTweetSendShareSend
Previous News

No Inner Line Permit Required for Domestic Tourists in Ladakh

Next News

Attempt of Murder on Tripura CM Biplab Dev; 3 attackers arrested

Related News

Self-Help Group from Thanjavur wins PM’s praise in Mann Ki Baat

Self-Help Group from Thanjavur wins PM’s praise in Mann Ki Baat

#MannKiBaat: Yoga Day 2022 to be unique and will follow Sun’s ‘Guardian Ring’ : PM Modi

#MannKiBaat: Yoga Day 2022 to be unique and will follow Sun’s ‘Guardian Ring’ : PM Modi

Bill Gates lauds India’s vaccination drive in meeting with Mansukh Mandaviya at Davos

Bill Gates lauds India’s vaccination drive in meeting with Mansukh Mandaviya at Davos

Indian Railways’ engineering marvel, New Pamban Bridge, to be ready in a year

Indian Railways’ engineering marvel, New Pamban Bridge, to be ready in a year

India’s daily cases fall below 3,000-mark, logs in 2,568 new COVID-19 infections

India reports 2,828 new COVID-19 cases, 14 deaths in last 24 hours

Systematic Uyghur genocide depicts human rights abuses against ethnic minorities in China: Report

Chinese Minister says China’s human rights protection will be aligned to national ‘conditions’

Comments

The comments posted here/below/in the given space are not on behalf of Organiser. The person posting the comment will be in sole ownership of its responsibility. According to the central government's IT rules, obscene or offensive statement made against a person, religion, community or nation is a punishable offense, and legal action would be taken against people who indulge in such activities.

Latest News

Self-Help Group from Thanjavur wins PM’s praise in Mann Ki Baat

Self-Help Group from Thanjavur wins PM’s praise in Mann Ki Baat

#MannKiBaat: Yoga Day 2022 to be unique and will follow Sun’s ‘Guardian Ring’ : PM Modi

#MannKiBaat: Yoga Day 2022 to be unique and will follow Sun’s ‘Guardian Ring’ : PM Modi

Bill Gates lauds India’s vaccination drive in meeting with Mansukh Mandaviya at Davos

Bill Gates lauds India’s vaccination drive in meeting with Mansukh Mandaviya at Davos

Indian Railways’ engineering marvel, New Pamban Bridge, to be ready in a year

Indian Railways’ engineering marvel, New Pamban Bridge, to be ready in a year

India’s daily cases fall below 3,000-mark, logs in 2,568 new COVID-19 infections

India reports 2,828 new COVID-19 cases, 14 deaths in last 24 hours

Systematic Uyghur genocide depicts human rights abuses against ethnic minorities in China: Report

Chinese Minister says China’s human rights protection will be aligned to national ‘conditions’

HUGE Security layer deployed as PM Modi & Amit Shah to attend GT vs RR IPL Final

HUGE Security layer deployed as PM Modi & Amit Shah to attend GT vs RR IPL Final

Kerala govt hand in glove with terrorist groups: MoS V Muraleedharan on PFI sloganeering

PM Modi lauds success of cooperatives in Gujarat, says self-reliance solution to many difficulties faced by the country

PM Modi lauds success of cooperatives in Gujarat, says self-reliance solution to many difficulties faced by the country

US slams China for ‘restricting, manipulating’ UN human rights chief’s visit

US slams China for ‘restricting, manipulating’ UN human rights chief’s visit

  • Circulation
  • Advertise
  • About Us
  • Contact Us
  • Privacy Policy

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies

No Result
View All Result
  • Home
  • Bharat
  • World
  • Editorial
  • Analysis
  • Opinion
  • Defence
  • Culture
  • Sports
  • Business
  • RSS in News
  • Special Report
  • Sci & Tech
  • Entertainment
  • Education
  • Books
  • Interviews
  • Travel
  • Health
  • Obituary
  • Subscribe
  • About Us
  • Advertise
  • Circulation
  • Contact Us
  • Privacy Policy

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies